• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reporting of drug reaction with eosinophilia and systemic symptoms from 2002 to 2019 in the US Food and Drug Administration Adverse Event Reporting System.

作者信息

Bluestein Sara Beth, Yu Roger, Stone Cosby, Phillips Elizabeth J

机构信息

Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn.

Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn; Pritzker School of Medicine, University of Chicago, Chicago, Ill.

出版信息

J Allergy Clin Immunol Pract. 2021 Aug;9(8):3208-3211.e1. doi: 10.1016/j.jaip.2021.05.008. Epub 2021 May 24.

DOI:10.1016/j.jaip.2021.05.008
PMID:34033979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8355126/
Abstract
摘要

相似文献

1
Reporting of drug reaction with eosinophilia and systemic symptoms from 2002 to 2019 in the US Food and Drug Administration Adverse Event Reporting System.2002年至2019年美国食品药品监督管理局不良事件报告系统中嗜酸性粒细胞增多和全身症状药物反应的报告
J Allergy Clin Immunol Pract. 2021 Aug;9(8):3208-3211.e1. doi: 10.1016/j.jaip.2021.05.008. Epub 2021 May 24.
2
Prediction and management of drug reaction with eosinophilia and systemic symptoms (DRESS).伴嗜酸性粒细胞增多和全身症状的药物反应（DRESS）的预测与管理。
Expert Opin Drug Metab Toxicol. 2017 Jul;13(7):701-704. doi: 10.1080/17425255.2017.1297422. Epub 2017 Mar 1.
3
US Food and Drug Administration warning about the risk of drug reaction with eosinophilia and systemic symptoms with ziprasidone.美国食品药品监督管理局关于齐拉西酮所致药物反应伴嗜酸性粒细胞增多和全身症状风险的警告。
J Clin Psychiatry. 2015 Sep;76(9):e1138-9. doi: 10.4088/JCP.15l09921.
4
Sorafenib Toxicity Mimicking Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome.索拉非尼毒性酷似药物超敏反应伴嗜酸性粒细胞增多和全身症状（DRESS）综合征。
J Drugs Dermatol. 2019 May 1;18(5):468-469.
5
Vemurafenib Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Disproportionality Analysis in FAERS Database.威罗菲尼致药物反应伴嗜酸性粒细胞增多和全身症状（DRESS）：FAERS 数据库中的比例失调分析。
Curr Rev Clin Exp Pharmacol. 2021;16(2):168-173. doi: 10.2174/1574884715666200628113508.
6
Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis.利用社交媒体报告药物不良反应来补充美国食品和药物管理局不良事件报告系统：比较分析。
JMIR Public Health Surveill. 2020 Sep 30;6(3):e19266. doi: 10.2196/19266.
7
DRESS syndrome presenting like septic shock.表现为感染性休克的药物超敏反应综合征
QJM. 2013 Jul;106(7):671-3. doi: 10.1093/qjmed/hct050. Epub 2013 Mar 8.
8
Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.药物相关性急性肾损伤在美国食品和药物管理局不良事件报告系统数据库中的识别。
Pharmacotherapy. 2018 Aug;38(8):785-793. doi: 10.1002/phar.2152. Epub 2018 Jul 13.
9
The Impact of Litigation-Associated Reports on Signal Identification in the US FDA's Adverse Event Reporting System.诉讼相关报告对美国食品药品监督管理局不良事件报告系统中信号识别的影响。
Drug Saf. 2019 Oct;42(10):1199-1201. doi: 10.1007/s40264-019-00834-1.
10
[Evaluation of the Association of Hand-Foot Syndrome with Anticancer Drugs Using the US Food and Drug Administration Adverse Event Reporting System (FAERS) and Japanese Adverse Drug Event Report (JADER) Databases].使用美国食品药品监督管理局不良事件报告系统（FAERS）和日本药品不良事件报告（JADER）数据库评估手足综合征与抗癌药物的相关性
Yakugaku Zasshi. 2016;136(3):507-15. doi: 10.1248/yakushi.15-00222.

引用本文的文献

1
Clinical diagnosis and management of drug reaction with eosinophilia and systemic symptoms (DRESS) in children: An EAACI position paper.儿童药物超敏反应伴嗜酸性粒细胞增多和全身症状（DRESS）的临床诊断与管理：欧洲变态反应和临床免疫学会立场文件
Pediatr Allergy Immunol. 2025 Jul;36(7):e70103. doi: 10.1111/pai.70103.
2
HLA-B Alleles with Shared Peptide Binding Specificities Define Global Risk of Cotrimoxazole-induced SCAR.具有共享肽结合特异性的HLA - B等位基因决定了复方新诺明诱导的严重皮肤不良反应的全球风险。
medRxiv. 2025 May 28:2025.05.28.25328237. doi: 10.1101/2025.05.28.25328237.
3
Specific clinical features define HLA-A∗32:01-positive vancomycin drug reaction with eosinophilia and systemic symptoms: A multi-institution cross-sectional study.

本文引用的文献

1
Emerging Causes of Drug-Induced Anaphylaxis: A Review of Anaphylaxis-Associated Reports in the FDA Adverse Event Reporting System (FAERS).药物性过敏反应的新病因：FDA 不良事件报告系统（FAERS）中与过敏反应相关报告的综述。
J Allergy Clin Immunol Pract. 2021 Feb;9(2):819-829.e2. doi: 10.1016/j.jaip.2020.09.021. Epub 2020 Sep 28.
2
HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms.HLA-A*32:01 与万古霉素诱导的嗜酸性粒细胞增多和全身症状药物反应密切相关。
J Allergy Clin Immunol. 2019 Jul;144(1):183-192. doi: 10.1016/j.jaci.2019.01.045. Epub 2019 Feb 16.
3
特定临床特征定义了伴有嗜酸性粒细胞增多和全身症状的HLA-A∗32:01阳性万古霉素药物反应：一项多机构横断面研究。
J Allergy Clin Immunol Pract. 2025 Aug;13(8):2182-2185.e1. doi: 10.1016/j.jaip.2025.05.027. Epub 2025 May 22.
4
Drug reaction with eosinophilia and systemic symptoms.药物超敏反应伴嗜酸性粒细胞增多和全身症状。
Intern Emerg Med. 2025 May 14. doi: 10.1007/s11739-025-03966-8.
5
Identification of novel signal of proton pump inhibitor-associated drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis.质子泵抑制剂相关药物反应伴嗜酸性粒细胞增多和全身症状的新型信号识别：一项比例失调分析。
Int J Clin Pharm. 2024 Dec;46(6):1381-1390. doi: 10.1007/s11096-024-01778-y. Epub 2024 Jul 23.
6
A review of drug-induced liver injury with rash, eosinophilia, and systemic symptoms (DRESS) syndrome: Cutaneous manifestations, clinical features, and management.药物性肝损伤伴皮疹、嗜酸性粒细胞增多和全身症状（DRESS）综合征综述：皮肤表现、临床特征及管理
Clin Liver Dis (Hoboken). 2024 May 31;23(1):e0198. doi: 10.1097/CLD.0000000000000198. eCollection 2024 Jan-Jun.
7
How to Define and Manage Low-Risk Drug Allergy Labels.如何定义和管理低风险药物过敏标签。
J Allergy Clin Immunol Pract. 2024 May;12(5):1095-1106. doi: 10.1016/j.jaip.2024.03.021.
8
Severe cutaneous adverse reactions.严重皮肤不良反应。
Nat Rev Dis Primers. 2024 Apr 25;10(1):30. doi: 10.1038/s41572-024-00514-0.
9
Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries.两则前瞻性药物性肝损伤登记研究中与药物过敏伴嗜酸性粒细胞增多和全身症状相关的药物性肝损伤特征。
Arch Toxicol. 2024 Jan;98(1):303-325. doi: 10.1007/s00204-023-03630-0. Epub 2023 Dec 5.
10
Vancomycin-Induced Liver Injury, DRESS, and HLA-A∗32:01.万古霉素所致肝损伤、药物超敏反应伴嗜酸性粒细胞增多和系统症状（DRESS）与HLA - A∗32:01
J Allergy Clin Immunol Pract. 2024 Jan;12(1):168-174.e2. doi: 10.1016/j.jaip.2023.09.011. Epub 2023 Sep 20.
Controversies in drug allergy: Testing for delayed reactions.
药物过敏的争议：迟发性反应的检测。
J Allergy Clin Immunol. 2019 Jan;143(1):66-73. doi: 10.1016/j.jaci.2018.10.030. Epub 2018 Dec 17.
4
Clinical, Viral and Genetic Characteristics of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in Shanghai, China.中国上海药物反应伴嗜酸性粒细胞增多和全身症状（DRESS）的临床、病毒和遗传特征。
Acta Derm Venereol. 2018 Apr 16;98(4):401-405. doi: 10.2340/00015555-2867.
5
HLA-A*31:01 and carbamazepine-induced DRESS syndrom in a sample of North African population.HLA-A*31:01 与卡马西平诱导的北非人群中的 DRESS 综合征。
Seizure. 2017 Dec;53:42-46. doi: 10.1016/j.seizure.2017.10.018. Epub 2017 Oct 27.
6
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System.药物超敏反应伴嗜酸性粒细胞增多和全身症状（DRESS）：药物、病毒与免疫系统之间的相互作用
Int J Mol Sci. 2017 Jun 9;18(6):1243. doi: 10.3390/ijms18061243.
7
HLA-B (*) 58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand.别嘌醇所致皮肤不良反应的HLA - B (*) 58:01：对泰国临床解读的意义
Front Pharmacol. 2016 Jul 18;7:186. doi: 10.3389/fphar.2016.00186. eCollection 2016.
8
Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS).药物性假性淋巴瘤和药物超敏反应综合征（药物疹伴嗜酸性粒细胞增多和全身症状：DRESS）。
Semin Cutan Med Surg. 1996 Dec;15(4):250-7. doi: 10.1016/s1085-5629(96)80038-1.